Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling

Show simplified metadata
dc.contributor.authorLengner, Christopher J.
dc.contributor.authorSteinman, Heather Anne
dc.contributor.authorGagnon, James
dc.contributor.authorSmith, Thomas W.
dc.contributor.authorHenderson, Janet E.
dc.contributor.authorKream, Barbara E.
dc.contributor.authorStein, Gary S.
dc.contributor.authorLian, Jane B.
dc.contributor.authorJones, Stephen N.
dc.contributor.departmentDepartment of Pathology
dc.contributor.departmentDepartment of Cell Biology
dc.contributor.departmentDepartment of Cancer Biology
dc.contributor.departmentMorningside Graduate School of Biomedical Sciences
dc.date2022-08-11T08:09:00.000
dc.date.accessioned2022-08-23T16:15:10Z
dc.date.available2022-08-23T16:15:10Z
dc.date.issued2006-03-15
dc.date.submitted2008-10-22
dc.description.abstractMdm2 is required to negatively regulate p53 activity at the peri-implantation stage of early mouse development. However, the absolute requirement for Mdm2 throughout embryogenesis and in organogenesis is unknown. To explore Mdm2-p53 signaling in osteogenesis, Mdm2-conditional mice were bred with Col3.6-Cre-transgenic mice that express Cre recombinase in osteoblast lineage cells. Mdm2-conditional Col3.6-Cre mice die at birth and display multiple skeletal defects. Osteoblast progenitor cells deleted for Mdm2 have elevated p53 activity, reduced proliferation, reduced levels of the master osteoblast transcriptional regulator Runx2, and reduced differentiation. In contrast, p53-null osteoprogenitor cells have increased proliferation, increased expression of Runx2, increased osteoblast maturation, and increased tumorigenic potential, as mice specifically deleted for p53 in osteoblasts develop osteosarcomas. These results demonstrate that p53 plays a critical role in bone organogenesis and homeostasis by negatively regulating bone development and growth and by suppressing bone neoplasia and that Mdm2-mediated inhibition of p53 function is a prerequisite for Runx2 activation, osteoblast differentiation, and proper skeletal formation.
dc.identifier.citationJ Cell Biol. 2006 Mar 13;172(6):909-21. <a href="http://dx.doi.org/10.1083/jcb.200508130">Link to article on publisher's site</a>
dc.identifier.contextkey654566
dc.identifier.doi10.1083/jcb.200508130
dc.identifier.issn0021-9525 (Print)
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/674
dc.identifier.pmid16533949
dc.identifier.submissionpathgsbs_sp/674
dc.identifier.urihttps://hdl.handle.net/20.500.14038/34023
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16533949&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1083/jcb.200508130
dc.source.issue6
dc.source.journaltitleThe Journal of cell biology
dc.source.pages909-21
dc.source.volume172
dc.titleOsteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling
dc.typeJournal Article
dspace.entity.typePublication
html.description.abstract<p>Mdm2 is required to negatively regulate p53 activity at the peri-implantation stage of early mouse development. However, the absolute requirement for Mdm2 throughout embryogenesis and in organogenesis is unknown. To explore Mdm2-p53 signaling in osteogenesis, Mdm2-conditional mice were bred with Col3.6-Cre-transgenic mice that express Cre recombinase in osteoblast lineage cells. Mdm2-conditional Col3.6-Cre mice die at birth and display multiple skeletal defects. Osteoblast progenitor cells deleted for Mdm2 have elevated p53 activity, reduced proliferation, reduced levels of the master osteoblast transcriptional regulator Runx2, and reduced differentiation. In contrast, p53-null osteoprogenitor cells have increased proliferation, increased expression of Runx2, increased osteoblast maturation, and increased tumorigenic potential, as mice specifically deleted for p53 in osteoblasts develop osteosarcomas. These results demonstrate that p53 plays a critical role in bone organogenesis and homeostasis by negatively regulating bone development and growth and by suppressing bone neoplasia and that Mdm2-mediated inhibition of p53 function is a prerequisite for Runx2 activation, osteoblast differentiation, and proper skeletal formation.</p>
Files
Collections
Morningside GSBS Scholarly Publications